Misako Nagasaka, MD, PhD, sheds light on neoadjuvant and adjuvant treatment options for patients with lung cancer.
ONCOLOGY® Companion, Volume 37, Supplement 12
During the European Society for Medical Oncology 2023, experts discussed updated results in key trials across the lung cancer space.
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
3
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
4
Palazestrant Combo Shows Preliminary Activity in ER+/HER2– Breast Cancer
5
